Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 7 Feb 2025 | 31 Jan 2025 |
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve unaudited financial results for the quarter ended 31st December 2024 and to consider any other matter with the permission of the Chairman. To consider and approve the Un-audited Financial Results and Limited Review Report for the Quarter ended 31st December, 2024. (As per BSE Announcement Dated on 07/02/2025) | ||
Board Meeting | 8 Nov 2024 | 29 Oct 2024 |
Quarterly Results To consider and approve the Un-audited Financial results and Limited Review Report for the Quarter and half year ended 30th September, 2024 and approving the revised Policy for Prevention of Sexual Harassment (POSH) at Workplace as per The Sexual Harassment of Women at Workplace (Prevention, Prohibition and; Redressal) Act, 2013 (Act). (As per BSE Announcement Dated on 08/11/2024) | ||
Board Meeting | 9 Aug 2024 | 2 Aug 2024 |
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve Unaudited financial results for the quarter ended 30th June 2024 and to consider any other matter with the permission of the Chairman. To consider and approve the Un-audited Financial results and Limited Review Report for the Quarter ended 30th June, 2024 (As per BSE Announcement Dated on 09/08/2024) | ||
Board Meeting | 17 May 2024 | 9 May 2024 |
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve Audited Financial Results for the Quarter and Financial Year ended 31st March 2024 and recommendation of Final Dividend if any for the Financial Year 2023-24. TO consider and approve the Audited Financial Results for the Financial Year ending 31st March, 2024, recommendation of Dividend for the Financial Year, 2023-24 and Fixation the date of AGM pf the Company. Results for Financial year ended 31st March, 2024 (As per BSE Announcement Dated on 17/05/2024) | ||
Board Meeting | 4 Apr 2024 | 4 Apr 2024 |
To consider and approve the following agendas: 1. Appointment of Mr. Manan Jayesh Vadhan as Company Secretary and Compliance Officer of the Company w.e.f. 04th April, 2024. 2. Approval on investment in Huoban Energy 5 Private Limited (SPV) for Solar Project, under group captive model under open access Appointment of Company Secretary and Compliance Officer (As Per BSE Announcement dated on 04.04.2024) |
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.